结直肠癌筛查中粪便免疫化学检测假阳性与假阴性的参与者相关危险因素:系统综述与Meta分析
该系统综述与Meta分析检索MEDLINE、EMBASE和Cochrane Library(截至2017年1月29日),纳入14项研究共54,499名参与者,评估结直肠癌筛查中与FIT假阳性及假阴性相关的参与者因素。男性与假阳性风险降低相关(RR 0.84),使用NSAIDs与假阳性风险升高相关(RR 1.16);男性、结直肠癌家族史、高血糖、高血压、肥胖及(既往)吸烟者假阴性风险显著升高。
要点
- 男性假阳性风险较低(RR 0.84),使用NSAIDs者假阳性风险较高(RR 1.16)。
- 男性、结直肠癌家族史、高血糖、高血压、肥胖及(既往)吸烟者假阴性风险显著升高。
- 年龄在Meta分析中未发现对FIT假阳性或假阴性有系统性影响。
核心结论
- 多个在FIT邀请时已知的危险因素与结直肠癌筛查中的假FIT结果相关。
- 该信息可用于识别阴性结果后面临假性安心或阳性结果后接受不必要结肠镜的人群,并进一步优化结直肠癌筛查效果。
研究设计与样本
- 系统综述与Meta分析,检索MEDLINE、EMBASE和Cochrane Library(2017年1月29日之前发表的文献)。
- 纳入14项研究,共54,499名参与者,评估FIT邀请时已知的参与者相关危险因素与假FIT结果(进展期肿瘤的存在/缺失)的关联。
- 使用QUIPS工具评估偏倚风险,对每个危险因素计算汇总相对危险度及95%置信区间。
主要发现
- 男性与假阳性风险显著降低相关(RR 0.84,95%CI 0.74-0.94)。
- 使用非甾体抗炎药(NSAIDs)者假阳性风险较高(RR 1.16,95%CI 1.06-1.27)。
- 使用抗凝药是研究最多的因素,对FIT阳性无显著影响。
- 男性(RR 1.83,95%CI 1.53-2.19)、有结直肠癌家族史者(RR 1.61,95%CI 1.19-2.15)、高血糖者(RR 1.29,95%CI 1.02-1.65)、高血压者(RR 1.50,95%CI 1.14-1.98)、肥胖者(RR 1.38,95%CI 1.11-1.71)及(既往)吸烟者(RR 1.93,95%CI 1.52-2.45)假阴性风险均显著升高。
- 年龄在Meta分析中未发现对FIT假阳性或假阴性有系统性影响。
临床怎么用
- 作者认为,FIT邀请时已知的多个危险因素与假FIT结果相关,该信息可用于识别阴性结果后面临假性安心或阳性结果后接受不必要结肠镜的人群,并进一步优化结直肠癌筛查效果。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Colorectal cancer (CRC) screening using fecal immunochemical tests (FIT) may reduce CRC-related mortality but its effectiveness is influenced by the limited accuracy of FIT. Identifying individuals at increased risk of a false FIT result could improve screening, but the available evidence is conflicting. We performed a systematic review and meta-analysis on risk factors for false-positive and false-negative FIT results in CRC screening. METHODS: A systematic search in MEDLINE, EMBASE, and Cochrane Library identified publications (before 29 January 2017) on risk factors (known at time of FIT invitation) associated with false FIT results (presence/absence of advanced neoplasia) in a CRC screening setting. Risk of bias was assessed using QUIPS. In meta-analysis, summary relative risk ratios and corresponding 95% confidence intervals were calculated for each risk factor. RESULTS: Of 518 records identified, 14 studies with 54,499 participants in total were included for analysis. In meta-analysis, male sex was associated with a significantly lower risk of false-positivity (RR 0.84, CI 0.74-0.94), whereas participants using non-steroidal anti-inflammatory drugs (NSAIDs) had a higher risk (RR 1.16, CI 1.06-1.27). The use of anticoagulants was most frequently studied, without a significant effect on FIT positivity. Males (RR 1.83, CI 1.53-2.19), participants with a family history for CRC (RR 1.61, CI 1.19-2.15), hyperglycemia (RR 1.29, CI 1.02-1.65), hypertension (RR 1.50, CI 1.14-1.98), obesity (RR 1.38, CI 1.11-1.71), and (former) smokers (RR 1.93, CI 1.52-2.45) were all at significantly higher risk for false-negative results. Age was not found to have a systematic effect on either FIT false-positivity or false-negativity in meta-analysis. CONCLUSIONS: Multiple risk factors, known at time of FIT invitation, are associated with false FIT results in CRC screening. This information can be used to identify populations risking false reassurance after a negative result or unnecessary colonoscopy after a positive result, and to further optimize CRC screening effectiveness.
引用
- de Klerk CM, Vendrig LM, Bossuyt PM, et al. Participant-Related Risk Factors for False-Positive and False-Negative Fecal Immunochemical Tests in Colorectal Cancer Screening: Systematic Review and Meta-Analysis. Am J Gastroenterol. 2018. PMID: 30158713. doi:10.1038/s41395-018-0212-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。